Evidence map›Paper›PMID 23032787›Full record

ReviewBiochimica et biophysica acta2013

The G0/G1 switch gene 2 (G0S2): regulating metabolism and beyond.

Bradlee L Heckmann, Xiaodong Zhang, Xitao Xie, Jun Liu

Abstract readReview
In one paragraph

Review in Biochimica et biophysica acta, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 84 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
84citing papers in PubMed, 1 pooled it
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

84 citing papers in PubMed, 1 synthesis or guideline pooled it, 137 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Pareto optimality reveals an atlas of cellular archetypes.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  5. Article
  6. Burn Selection: How Fire Injury Shaped Human Evolution.BioEssays : news and reviews in molecular, cellular and developmental biology · 2026
    Review
  7. Article
  8. Article
  9. Article
  10. Epigenetics · 2025
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

24 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Bradlee L HeckmannDepartment of Biochemistry & Molecular Biology, Mayo Clinic, Scottsdale, Arizona 85259, USA.
Xiaodong Zhang
Xitao Xie
Jun Liu
Mayo Clinic in Arizona · US

Funding

Inhibition of ATGL-Mediated Lipolysis by G0S2R01DK089178 · NIDDK · UNIVERSITY OF KENTUCKY · PI LIU, JUN · 2010 to 2014
$1.7M
G0S2: a dual-function regulator of lipid and energy metabolismR56DK089178 · NIDDK · MAYO CLINIC ARIZONA · PI LIU, JUN · 2015 to 2015
$125k
NIDDK NIH HHS DK089178NIDDK NIH HHS R01 DK089178NIDDK NIH HHS R56 DK089178
6 · The paper itself

Abstract

The G0/G1 switch gene 2 (G0S2) was originally identified in blood mononuclear cells following induced cell cycle progression. Translation of G0S2 results in a small basic protein of 103 amino acids in size. It was initially believed that G0S2 mediates re-entry of cells from the G0 to G1 phase of the cell cycle. Recent studies have begun to reveal the functional aspects of G0S2 and its protein product in various cellular settings. To date the best-known function of G0S2 is its direct inhibitory capacity on the rate-limiting lipolytic enzyme adipose triglyceride lipase (ATGL). Other studies have illustrated key features of G0S2 including sub-cellular localization, expression profiles and regulation, and possible functions in cellular proliferation and differentiation. In this review we present the current knowledge base regarding all facets of G0S2, and pose a variety of questions and hypotheses pertaining to future research directions.

Indexed as

G1 PhaseResting Phase, Cell CycleCell Cycle ProteinsHumansCell Cycle ProteinsG0S2 protein, human

Identifiers

PMID23032787
PMCPMC3698047
OpenAlexW2056814396

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.